The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023
Drug & Device Law
DECEMBER 29, 2023
2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. Monsanto Co. ,
105 
Let's personalize your content